Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.74 +0.03 (+1.10%)
As of: Sep 30, 2026 · 11:55 AM EDT

Zentalis Pharmaceuticals (ZNTL) Common Equity (2019 - 2026)

Updated

Zentalis Pharmaceuticals (ZNTL) recorded Common Equity of $143.65 million in Q2 2026, down 47.7% from $274.5 million a year earlier and down 21.4% from the prior quarter.

Analysis

Zentalis Pharmaceuticals (ZNTL) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Zentalis Pharmaceuticals reported Common Equity of $216.2 million, down 35.9% from FY2024.

  • Annual Common Equity has a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
  • Across earlier years, Common Equity came in at $337.19 million in FY2024 (-22.9%), $437.39 million in FY2023 (+0.8%), $434.02 million in FY2022 (+19.1%) and $364.48 million in FY2021 (+9.3%).
  • The Q2 2026 figure is the lowest quarterly Common Equity since Q1 2020.
  • On a year-over-year basis, Common Equity has declined for nine consecutive quarters, with an average decline of 32.9% over the last eight quarters.
  • Peak year-over-year performance for Common Equity in the last five years was growth of 91.0% in Q2 2022, against a decline of 47.7% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $182.68 million (Q1 2026), $216.2 million (Q4 2025) and $252.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Zentalis Pharmaceuticals 186.34 Mn 186.34 Mn - 143.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 143.65 Mn
Mar 31, 2026 182.68 Mn
Dec 31, 2025 216.20 Mn
Sep 30, 2025 252.87 Mn
Jun 30, 2025 274.50 Mn
Mar 31, 2025 295.38 Mn
Dec 31, 2024 337.19 Mn
Sep 30, 2024 354.33 Mn
Jun 30, 2024 382.58 Mn
Mar 31, 2024 458.77 Mn
Dec 31, 2023 437.39 Mn
Sep 30, 2023 481.90 Mn
Jun 30, 2023 523.28 Mn
Mar 31, 2023 385.67 Mn
Dec 31, 2022 434.02 Mn
Sep 30, 2022 428.74 Mn
Jun 30, 2022 472.82 Mn
Mar 31, 2022 315.67 Mn
Dec 31, 2021 364.48 Mn
Sep 30, 2021 394.00 Mn
API Access

Zentalis Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ZNTL&period=max&api_key=YOUR_API_KEY